JAK2 and prostate cancer: Jak2-Stat5 signaling inhibitors potently suppress the growth and induce apoptosis of primary prostate cancer cells and castrate-resistant prostate cancer cells, this inhibitory effect was observed in 75% of primary tumors grown ex vivo in organ explant cultures [439].